tetano
Editor, Senior Moderator
Br J Dermatol
. 2020 Sep 24.
doi: 10.1111/bjd.19564. Online ahead of print.
Prevalence of mucocutaneous manifestations, oral and palmoplantar findings in 666 patients with COVID-19 in a field hospital in Spain
A Nuno-Gonzalez[SUP] 1 2 [/SUP], P Martin-Carrillo[SUP] 3 4 [/SUP], K Magaletsky[SUP] 1 2 [/SUP], M D Martin Rios[SUP] 5 [/SUP], C Herranz Ma?as[SUP] 1 [/SUP], J Artigas Almazan[SUP] 1 [/SUP], G Garc?a Casasola[SUP] 6 7 [/SUP], E Perez Castro[SUP] 4 [/SUP], A Gallego Arenas[SUP] 8 [/SUP], A Mayor Ibarguren[SUP] 1 2 [/SUP], M Feito Rodr?guez[SUP] 1 2 [/SUP], B Lozano Masdemont[SUP] 9 [/SUP], M Beato[SUP] 10 [/SUP], E Ruiz Bravo[SUP] 10 [/SUP], P Oliver[SUP] 11 [/SUP], M D Montero Vega[SUP] 12 [/SUP], P Herranz Pinto[SUP] 1 2 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (Covid-2019) has been associated with several cutaneous manifestations(1-3). A temporary field hospital was implemented during the pandemic peak in Madrid, Spain, to attend COVID-19 patients with mild to moderate pneumonia.
. 2020 Sep 24.
doi: 10.1111/bjd.19564. Online ahead of print.
Prevalence of mucocutaneous manifestations, oral and palmoplantar findings in 666 patients with COVID-19 in a field hospital in Spain
A Nuno-Gonzalez[SUP] 1 2 [/SUP], P Martin-Carrillo[SUP] 3 4 [/SUP], K Magaletsky[SUP] 1 2 [/SUP], M D Martin Rios[SUP] 5 [/SUP], C Herranz Ma?as[SUP] 1 [/SUP], J Artigas Almazan[SUP] 1 [/SUP], G Garc?a Casasola[SUP] 6 7 [/SUP], E Perez Castro[SUP] 4 [/SUP], A Gallego Arenas[SUP] 8 [/SUP], A Mayor Ibarguren[SUP] 1 2 [/SUP], M Feito Rodr?guez[SUP] 1 2 [/SUP], B Lozano Masdemont[SUP] 9 [/SUP], M Beato[SUP] 10 [/SUP], E Ruiz Bravo[SUP] 10 [/SUP], P Oliver[SUP] 11 [/SUP], M D Montero Vega[SUP] 12 [/SUP], P Herranz Pinto[SUP] 1 2 [/SUP]
Affiliations
- PMID: 32969503
- DOI: 10.1111/bjd.19564
Abstract
Coronavirus disease 2019 (Covid-2019) has been associated with several cutaneous manifestations(1-3). A temporary field hospital was implemented during the pandemic peak in Madrid, Spain, to attend COVID-19 patients with mild to moderate pneumonia.